Free Newsletter
NHS widens access, relaxes drug fees
The UK's National Health Service will now allow patients to receive NHS care even if they privately pay for drugs, and will implement measures to increase access to NHS-covered treatments.
Alan Johnson, the UK's health secretary, overturned a rule that had previously banned patients from receiving services if they paid for their own medications. At the same time, Michael Richards, the National Cancer Director, published a report that showed government plans to work on new pricing arrangements for new drugs as well as speed up the appraisal and approval process for new medications.
As a result, the public will have greater access to drugs for cancer and other terminal conditions. The move ends what some have called a "cruel practice" that prevented individuals from purchasing certain medications by removing other NHS benefits.
- see the full story at the Financial Times
Related Articles:
Costly cancer meds put NHS in quandary
Tories propose NICE approval reforms
UK politicians: Pay for drug performance
Does NICE want pricing power?
U.K. drug deal cuts prices 5%
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession






SHARE
WITH: